Publications 2025

Kindberg KM, Nordeng J, Langseth MS, Schandiz H, Roald B, Solheim S, Seljeflot I, Stokke MK, Helseth R (2025)
IL-6R Signaling Is Associated with PAD4 and Neutrophil Extracellular Trap Formation in Patients with STEMI
26 (11)
DOI 10.3390/ijms26115348, PubMed 40508157

Publications 2024

Aune SK, Helseth R, Kalstad AA, Laake K, Åkra S, Arnesen H, Solheim S, Seljeflot I (2024)
Links Between Adipose Tissue Gene Expression of Gut Leakage Markers, Circulating Levels, Anthropometrics, and Diet in Patients with Coronary Artery Disease
17, 2177-2190
DOI 10.2147/DMSO.S438818, PubMed 38827167

Publications 2023

Myhre PL, Berge T, Kalstad AA, Tveit SH, Laake K, Schmidt EB, Solheim S, Arnesen H, Seljeflot I, Tveit A (2023)
Omega-3 fatty acid supplements and risk of atrial fibrillation and 'micro-atrial fibrillation': A secondary analysis from the OMEMI trial
42 (9), 1657-1660
DOI 10.1016/j.clnu.2023.07.002, PubMed 37515843

Nilsen DWT, Myhre PL, Solheim S, Tveit SH, Kalstad AA, Laake K, Tveit A, Seljeflot I (2023)
Total Bilirubin Yields Prognostic Information Following a Myocardial Infarction in the Elderly
12 (6)
DOI 10.3390/antiox12061157, PubMed 37371887

Opstad TB, Papotti B, Åkra S, Hansen CH, Braathen B, Tønnessen T, Solheim S, Seljeflot I (2023)
Sirtuin1, not NAMPT, possesses anti-inflammatory effects in epicardial, pericardial and subcutaneous adipose tissue in patients with CHD
21 (1), 644
DOI 10.1186/s12967-023-04518-4, PubMed 37730614

Papotti B, Opstad TB, Åkra S, Tønnessen T, Braathen B, Hansen CH, Arnesen H, Solheim S, Seljeflot I, Ronda N (2023)
Macrophage polarization markers in subcutaneous, pericardial, and epicardial adipose tissue are altered in patients with coronary heart disease
10, 1055069
DOI 10.3389/fcvm.2023.1055069, PubMed 36937936

Warlo EMK, Kalstad AA, Myhre PL, Solheim S, Arnesen H, Tveit A, Holme PA, Seljeflot I, Bratseth V (2023)
von Willebrand factor, ADAMTS-13, and thrombospondin 1 in relation to clinical outcomes in elderly patients with a recent myocardial infarction
7 (4), 100164
DOI 10.1016/j.rpth.2023.100164, PubMed 37255854

Publications 2022

Berge T, Myhre PL, Kalstad AA, Laake K, Tveit SH, Onarheim S, Solheim S, Seljeflot I, Arnesen H, Tveit A (2022)
Screen-Detected Atrial Fibrillation and "Micro-Atrial Fibrillation" and Risk of Cardiovascular Events after Myocardial Infarction in Elderly Patients
148 (1), 72-77
DOI 10.1159/000528726, PubMed 36538900

Bratseth V, Nordeng J, Helseth R, Solheim S, Åkra S, Arnesen H, Chiva-Blanch G, Seljeflot I (2022)
Circulating Microvesicles in Association with the NLRP3 Inflammasome in Coronary Thrombi from STEMI Patients
10 (9)
DOI 10.3390/biomedicines10092196, PubMed 36140297

Myhre PL, Kalstad AA, Tveit SH, Laake K, Schmidt EB, Smith P, Nilsen DWT, Tveit A, Solheim S, Arnesen H, Seljeflot I (2022)
Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial
291 (5), 637-647
DOI 10.1111/joim.13442, PubMed 34982486

Nordeng J, Schandiz H, Solheim S, Åkra S, Hoffman P, Roald B, Bendz B, Arnesen H, Helseth R, Seljeflot I (2022)
TIMP-1 expression in coronary thrombi associate with myocardial injury in ST-elevation myocardial infarction patients
33 (6), 446-455
DOI 10.1097/MCA.0000000000001128, PubMed 35102064

Nordeng J, Solheim S, Åkra S, Schandiz H, Hoffmann P, Roald B, Bendz B, Arnesen H, Helseth R, Seljeflot I (2022)
Gene expression of fibrinolytic markers in coronary thrombi
20 (1), 23
DOI 10.1186/s12959-022-00383-1, PubMed 35488283

Opstad TB, Nordeng J, Pettersen AR, Åkra S, Bratseth V, Zaidi H, Helseth R, Solheim S, Seljeflot I (2022)
The NLRP3 Genetic Variant (rs10754555) Reduces the Risk of Adverse Outcome in Middle-Aged Patients with Chronic Coronary Syndrome
2022, 2366695
DOI 10.1155/2022/2366695, PubMed 36582742

Opstad TB, Solheim S, Pettersen AR, Kalstad AA, Arnesen H, Seljeflot I (2022)
TERT and TET2 Genetic Variants Affect Leukocyte Telomere Length and Clinical Outcome in Coronary Artery Disease Patients-A Possible Link to Clonal Hematopoiesis
10 (8)
DOI 10.3390/biomedicines10082027, PubMed 36009574

Åkra S, Seljeflot I, Braathen B, Bratseth V, Hansen CH, Arnesen H, Tønnessen T, Solheim S (2022)
The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery
48, 47-54
DOI 10.1016/j.athplu.2022.03.005, PubMed 36644557

Publications 2021

Aune SK, Byrkjeland R, Solheim S, Arnesen H, Trøseid M, Awoyemi A, Seljeflot I, Helseth R (2021)
Gut related inflammation and cardiorespiratory fitness in patients with CAD and type 2 diabetes: a sub-study of a randomized controlled trial on exercise training
13 (1), 36
DOI 10.1186/s13098-021-00655-2, PubMed 33794977

Aune SK, Cwikiel J, Flaa A, Arnesen H, Solheim S, Awoyemi A, Trøseid M, Seljeflot I, Helseth R (2021)
Gut Leakage Markers in Response to Strenuous Exercise in Patients with Suspected Coronary Artery Disease
10 (9)
DOI 10.3390/cells10092193, PubMed 34571843

Awoyemi A, Mayerhofer C, Felix AS, Hov JR, Moscavitch SD, Lappegård KT, Hovland A, Halvorsen S, Halvorsen B, Gregersen I, Svardal A, Berge RK, Hansen SH, Götz A, Holm K, Aukrust P, Åkra S, Seljeflot I, Solheim S, Lorenzo A, Gullestad L, Trøseid M, Broch K (2021)
Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial
70, 103511
DOI 10.1016/j.ebiom.2021.103511, PubMed 34329947

Chiva-Blanch G, Bratseth V, Laake K, Arnesen H, Solheim S, Schmidt EB, Badimon L, Seljeflot I (2021)
One year of omega 3 polyunsaturated fatty acid supplementation does not reduce circulating prothrombotic microvesicles in elderly subjects after suffering a myocardial infarction
40 (12), 5674-5677
DOI 10.1016/j.clnu.2021.10.007, PubMed 34742136

Kalstad AA, Myhre PL, Laake K, Opstad TB, Tveit A, Solheim S, Arnesen H, Seljeflot I (2021)
Biomarkers of ageing and cardiac remodeling are associated with atrial fibrillation
55 (4), 213-219
DOI 10.1080/14017431.2021.1889653, PubMed 33650449

Nordeng J, Schandiz H, Solheim S, Åkra S, Hoffman P, Roald B, Bendz B, Arnesen H, Helseth R, Seljeflot I (2021)
The Inflammasome Signaling Pathway Is Actively Regulated and Related to Myocardial Damage in Coronary Thrombi from Patients with STEMI
2021, 5525917
DOI 10.1155/2021/5525917, PubMed 34135690

Zaidi H, Byrkjeland R, Njerve IU, Åkra S, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2021)
Adiponectin in relation to exercise and physical performance in patients with type 2 diabetes and coronary artery disease
10 (1), 612-620
DOI 10.1080/21623945.2021.1996699, PubMed 34779349

Publications 2020

Bratseth V, Margeirsdottir HD, Chiva-Blanch G, Heier M, Solheim S, Arnesen H, Dahl-Jørgensen K, Seljeflot I (2020)
Annexin V⁺ Microvesicles in Children and Adolescents with Type 1 Diabetes: A Prospective Cohort Study
2020, 7216863
DOI 10.1155/2020/7216863, PubMed 32309448

Bratseth V, Margeirsdottir HD, Heier M, Solheim S, Arnesen H, Dahl-Jørgensen K, Seljeflot I (2020)
Procoagulant activity in children and adolescents on intensive insulin therapy
21 (3), 496-504
DOI 10.1111/pedi.12978, PubMed 31943582

Danielsen SO, Moons P, Leegaard M, Solheim S, Tønnessen T, Lie I (2020)
Facilitators of and barriers to reducing thirty-day readmissions and improving patient-reported outcomes after surgical aortic valve replacement: a process evaluation of the AVRre trial
20 (1), 256
DOI 10.1186/s12913-020-05125-5, PubMed 32220252

Holte KB, Svanteson M, Hanssen KF, Sveen KA, Seljeflot I, Solheim S, Sell DR, Monnier VM, Berg TJ (2020)
Collagen methionine sulfoxide and glucuronidine/LW-1 are markers of coronary artery disease in long-term survivors with type 1 diabetes. The Dialong study
15 (5), e0233174
DOI 10.1371/journal.pone.0233174, PubMed 32401813

Kalstad AA, Myhre PL, Laake K, Tveit SH, Schmidt EB, Smith P, Nilsen DWT, Tveit A, Fagerland MW, Solheim S, Seljeflot I, Arnesen H, OMEMI Investigators (2020)
Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction: A Randomized, Controlled Trial
143 (6), 528-539
DOI 10.1161/CIRCULATIONAHA.120.052209, PubMed 33191772

Langseth MS, Andersen GØ, Husebye T, Arnesen H, Zucknick M, Solheim S, Eritsland J, Seljeflot I, Opstad TB, Helseth R (2020)
Neutrophil extracellular trap components and myocardial recovery in post-ischemic acute heart failure
15 (10), e0241333
DOI 10.1371/journal.pone.0241333, PubMed 33119664

Langseth MS, Helseth R, Ritschel V, Hansen CH, Andersen GØ, Eritsland J, Halvorsen S, Fagerland MW, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2020)
Double-Stranded DNA and NETs Components in Relation to Clinical Outcome After ST-Elevation Myocardial Infarction
10 (1), 5007
DOI 10.1038/s41598-020-61971-7, PubMed 32193509

Opstad TB, Berg TJ, Holte KB, Arnesen H, Solheim S, Seljeflot I (2020)
Reduced leukocyte telomere lengths and sirtuin 1 gene expression in long-term survivors of type 1 diabetes: A Dialong substudy
12 (7), 1183-1192
DOI 10.1111/jdi.13470, PubMed 33249778

Opstad TB, Kalstad AA, Holte KB, Berg TJ, Solheim S, Arnesen H, Seljeflot I (2020)
Shorter Leukocyte Telomere Lengths in Healthy Relatives of Patients with Coronary Heart Disease
23 (4), 324-332
DOI 10.1089/rej.2019.2258, PubMed 31805818

Publications 2019

Awoyemi A, Trøseid M, Arnesen H, Solheim S, Seljeflot I (2019)
Effects of dietary intervention and n-3 PUFA supplementation on markers of gut-related inflammation and their association with cardiovascular events in a high-risk population
286, 53-59
DOI 10.1016/j.atherosclerosis.2019.05.004, PubMed 31100620

Bratseth V, Chiva-Blanch G, Byrkjeland R, Solheim S, Arnesen H, Seljeflot I (2019)
Elevated levels of circulating microvesicles in coronary artery disease patients with type 2 diabetes and albuminuria: Effects of exercise training
16 (5), 431-439
DOI 10.1177/1479164119843094, PubMed 31023084

Chiva-Blanch G, Laake K, Myhre P, Bratseth V, Arnesen H, Solheim S, Badimon L, Seljeflot I (2019)
High Adherence to the Nordic Diet Is Associated with Lower Levels of Total and Platelet-Derived Circulating Microvesicles in a Norwegian Population
11 (5)
DOI 10.3390/nu11051114, PubMed 31109111

Danielsen SO, Moons P, Sandvik L, Leegaard M, Solheim S, Tønnessen T, Lie I (2019)
Impact of telephone follow-up and 24/7 hotline on 30-day readmission rates following aortic valve replacement -A randomized controlled trial
300, 66-72
DOI 10.1016/j.ijcard.2019.07.087, PubMed 31387822

Holte KB, Svanteson M, Hanssen KF, Haig Y, Solheim S, Berg TJ (2019)
Undiagnosed coronary artery disease in long-term type 1 diabetes. The Dialong study
33 (5), 383-389
DOI 10.1016/j.jdiacomp.2019.01.006, PubMed 30846232

Kalstad AA, Tveit S, Myhre PL, Laake K, Opstad TB, Tveit A, Schmidt EB, Solheim S, Arnesen H, Seljeflot I (2019)
Leukocyte telomere length and serum polyunsaturated fatty acids, dietary habits, cardiovascular risk factors and features of myocardial infarction in elderly patients
19 (1), 376
DOI 10.1186/s12877-019-1383-9, PubMed 31881852

Zaidi H, Byrkjeland R, Njerve IU, Åkra S, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2019)
Effects of exercise training on inflammasome-related mediators and their associations to glucometabolic variables in patients with combined coronary artery disease and type 2 diabetes mellitus: Sub-study of a randomized control trial
16 (4), 360-368
DOI 10.1177/1479164119836922, PubMed 30939905

Zaidi H, Byrkjeland R, Njerve IU, Åkra S, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2019)
Effects of exercise training on markers of adipose tissue remodeling in patients with coronary artery disease and type 2 diabetes mellitus: sub study of the randomized controlled EXCADI trial
11, 109
DOI 10.1186/s13098-019-0508-9, PubMed 31890043

Publications 2018

Awoyemi A, Trøseid M, Arnesen H, Solheim S, Seljeflot I (2018)
Markers of metabolic endotoxemia as related to metabolic syndrome in an elderly male population at high cardiovascular risk: a cross-sectional study
10, 59
DOI 10.1186/s13098-018-0360-3, PubMed 30038669

Danielsen SO, Moons P, Sandven I, Leegaard M, Solheim S, Tønnessen T, Lie I (2018)
Thirty-day readmissions in surgical and transcatheter aortic valve replacement: A systematic review and meta-analysis
268, 85-91
DOI 10.1016/j.ijcard.2018.05.026, PubMed 29779575

Langseth MS, Opstad TB, Bratseth V, Solheim S, Arnesen H, Pettersen AÅ, Seljeflot I, Helseth R (2018)
Markers of neutrophil extracellular traps are associated with adverse clinical outcome in stable coronary artery disease
25 (7), 762-769
DOI 10.1177/2047487318760618, PubMed 29473463

Wieckowska-Luth M, Solheim S, Schulke A, Kirleis W (2018)
Towards a refined understanding of the use of coastal zones in the Mesolithic: New investigations on human-environment interactions in Telemark, southeastern Norway
J. Archaeol. Sci.-Rep., 17, 839-851
DOI 10.1016/j.jasrep.2017.12.045

Publications 2017

Bratseth V, Byrkjeland R, Njerve IU, Solheim S, Arnesen H, Seljeflot I (2017)
Procoagulant activity in patients with combined type 2 diabetes and coronary artery disease: No effects of long-term exercise training
14 (2), 144-151
DOI 10.1177/1479164116679080, PubMed 28111966

Byrkjeland R, Njerve IU, Arnesen H, Seljeflot I, Solheim S (2017)
Reduced endothelial activation after exercise is associated with improved HbA_1c in patients with type 2 diabetes and coronary artery disease
14 (2), 94-103
DOI 10.1177/1479164116679077, PubMed 28111980

Chiva-Blanch G, Laake K, Myhre P, Bratseth V, Arnesen H, Solheim S, Badimon L, Seljeflot I (2017)
Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity
12 (2), e0172558
DOI 10.1371/journal.pone.0172558, PubMed 28207887

Lie I, Danielsen SO, Tønnessen T, Solheim S, Leegaard M, Sandvik L, Wisløff T, Vangen J, Røsstad TH, Moons P (2017)
Determining the impact of 24/7 phone support on hospital readmissions after aortic valve replacement surgery (the AVRre study): study protocol for a randomised controlled trial
18 (1), 246
DOI 10.1186/s13063-017-1971-y, PubMed 28693599

Laake K, Seljeflot I, Schmidt EB, Myhre P, Tveit A, Norseth J, Arnesen H, Solheim S (2017)
Galectin-3, a marker of cardiac remodeling, is inversely related to serum levels of marine omega-3 fatty acids. A cross-sectional study
6, 2048004017729984
DOI 10.1177/2048004017729984, PubMed 28932392

Njerve IU, Åkra S, Weiss TW, Solheim S, Øvstebø R, Aass HCD, Byrkjeland R, Arnesen H, Seljeflot I (2017)
A Double-Blinded Randomized Study Investigating a Possible Anti-Inflammatory Effect of Saxagliptin versus Placebo as Add-On Therapy in Patients with Both Type 2 Diabetes And Stable Coronary Artery Disease
2017, 5380638
DOI 10.1155/2017/5380638, PubMed 28596642

Publications 2016

Byrkjeland R, Stensæth KH, Anderssen S, Njerve IU, Arnesen H, Seljeflot I, Solheim S (2016)
Effects of exercise training on carotid intima-media thickness in patients with type 2 diabetes and coronary artery disease. Influence of carotid plaques
15, 13
DOI 10.1186/s12933-016-0336-2, PubMed 26801098

Helseth R, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2016)
The Time Course of Markers of Neutrophil Extracellular Traps in Patients Undergoing Revascularisation for Acute Myocardial Infarction or Stable Angina Pectoris
2016, 2182358
DOI 10.1155/2016/2182358, PubMed 28074081

Laake K, Seljeflot I, Schmidt EB, Myhre P, Tveit A, Arnesen H, Solheim S (2016)
Serum Fatty Acids, Traditional Risk Factors, and Comorbidity as Related to Myocardial Injury in an Elderly Population with Acute Myocardial Infarction
2016, 4945720
DOI 10.1155/2016/4945720, PubMed 26989512

Myhre PL, Laake K, Seljeflot I, Solheim S, Arnesen H (2016)
[Clinical research on elderly]
136 (3), 208
DOI 10.4045/tidsskr.15.1300, PubMed 26860377

Njerve IU, Byrkjeland R, Arnesen H, Åkra S, Solheim S, Seljeflot I (2016)
Effects of long-term exercise training on adipose tissue expression of fractalkine and MCP-1 in patients with type 2 diabetes and stable coronary artery disease: a substudy of a randomized controlled trial
9, 55-62
DOI 10.2147/DMSO.S96299, PubMed 27042130

Publications 2015

Byrkjeland R, Njerve IU, Anderssen S, Arnesen H, Seljeflot I, Solheim S (2015)
Effects of exercise training on HbA1c and VO2peak in patients with type 2 diabetes and coronary artery disease: A randomised clinical trial
12 (5), 325-33
DOI 10.1177/1479164115590552, PubMed 26092822

Dudek D, Siudak Z, Solheim S (2015)
New model of secondary cardiovascular prevention for patients after acute coronary syndromes in Poland with regard to Norwegian experiences
74 (2), 101-3
DOI 10.5603/KP.a2015.0176, PubMed 26365935

Helseth R, Opstad T, Solheim S, Lunde K, Arnesen H, Seljeflot I (2015)
The Effect of Intracoronary Stem Cell Injection on Markers of Leukocyte Activation in Acute Myocardial Infarction
6 (1), 209-215
DOI 10.14740/cr375w, PubMed 28197227

Helseth R, Weiss TW, Opstad TB, Siegbahn A, Solheim S, Freynhofer MK, Huber K, Arnesen H, Seljeflot S (2015)
Associations between circulating proteins and corresponding genes expressed in coronary thrombi in patients with acute myocardial infarction
136 (6), 1240-4
DOI 10.1016/j.thromres.2015.10.005, PubMed 26475405

Laake K, Seljeflot I, Fagerland MW, Njerve IU, Arnesen H, Solheim S (2015)
Effects on serum fractalkine by diet and omega-3 fatty acid intervention: relation to clinical outcome
2015, 373070
DOI 10.1155/2015/373070, PubMed 25733777

Publications 2014

Byrkjeland R, Edvardsen E, Njerve IU, Arnesen H, Seljeflot I, Solheim S (2014)
Insulin levels and HOMA index are associated with exercise capacity in patients with type 2 diabetes and coronary artery disease
6 (1), 36
DOI 10.1186/1758-5996-6-36, PubMed 24612649

Furenes EB, Opstad TB, Solheim S, Lunde K, Arnesen H, Seljeflot I (2014)
The influence of autologous bone marrow stem cell transplantation on matrix metalloproteinases in patients treated for acute ST-elevation myocardial infarction
2014, 385901
DOI 10.1155/2014/385901, PubMed 25294955

Helseth R, Seljeflot I, Opstad T, Solheim S, Freynhofer M, Arnesen H, Huber K, Weiss T (2014)
Genes expressed in coronary thrombi are associated with ischemic time in patients with acute myocardial infarction
135 (2), 329-33
DOI 10.1016/j.thromres.2014.11.028, PubMed 25496999

Helseth R, Solheim S, Opstad T, Hoffmann P, Arnesen H, Seljeflot I (2014)
The time profile of Pentraxin 3 in patients with acute ST-elevation myocardial infarction and stable angina pectoris undergoing percutaneous coronary intervention
2014, 608414
DOI 10.1155/2014/608414, PubMed 24737925

Laake K, Myhre P, Nordby LM, Seljeflot I, Abdelnoor M, Smith P, Tveit A, Arnesen H, Solheim S (2014)
Effects of ω3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled study
14, 74
DOI 10.1186/1471-2318-14-74, PubMed 24928284

Njerve IU, Solheim S, Lunde K, Hoffmann P, Arnesen H, Seljeflot I (2014)
Fractalkine levels are elevated early after PCI-treated ST-elevation myocardial infarction; no influence of autologous bone marrow derived stem cell injection
69 (1), 131-5
DOI 10.1016/j.cyto.2014.05.022, PubMed 24930044

Publications 2013

Hopp E, Bjørnerud A, Lunde K, Solheim S, Aakhus S, Arnesen H, Forfang K, Edvardsen T, Smith HJ (2013)
Perfusion MRI at rest in subacute and chronic myocardial infarct
54 (4), 401-11
DOI 10.1177/0284185113475605, PubMed 23401603

Solheim S, Seljeflot I, Lunde K, Bratseth V, Aakhus S, Forfang K, Arnesen H (2013)
Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy
11 (1), 1
DOI 10.1186/1477-9560-11-1, PubMed 23311309

Publications 2012

Bliksøen M, Mariero LH, Ohm IK, Haugen F, Yndestad A, Solheim S, Seljeflot I, Ranheim T, Andersen GØ, Aukrust P, Valen G, Vinge LE (2012)
Increased circulating mitochondrial DNA after myocardial infarction
158 (1), 132-4
DOI 10.1016/j.ijcard.2012.04.047, PubMed 22578950

Publications 2011

Grøgaard HK, Solheim S, Landsverk KS, Seljeflot I, Hoffmann P, Arnesen H, Ilebekk A (2011)
Circulating CD34⁺ progenitor cells and growth factors in patients treated with PCI for acute myocardial infarction or stable angina pectoris
71 (4), 322-9
DOI 10.3109/00365513.2011.565367, PubMed 21463159

Hopp E, Lunde K, Solheim S, Aakhus S, Arnesen H, Forfang K, Edvardsen T, Smith HJ (2011)
Regional myocardial function after intracoronary bone marrow cell injection in reperfused anterior wall infarction - a cardiovascular magnetic resonance tagging study
13 (1), 22
DOI 10.1186/1532-429X-13-22, PubMed 21414223

Solheim S, Seljeflot I, Lunde K, Bratseth V, Aakhus S, Forfang K, Arnesen H (2011)
The influence of intracoronary injection of bone marrow cells on prothrombotic markers in patients with acute myocardial infarction
130 (5), 765-8
DOI 10.1016/j.thromres.2011.11.045, PubMed 22192151

Publications 2010

Beitnes JO, Gjesdal O, Lunde K, Solheim S, Edvardsen T, Arnesen H, Forfang K, Aakhus S (2010)
Left ventricular systolic and diastolic function improve after acute myocardial infarction treated with acute percutaneous coronary intervention, but are not influenced by intracoronary injection of autologous mononuclear bone marrow cells: a 3 year serial echocardiographic sub-study of the randomized-controlled ASTAMI study
12 (2), 98-106
DOI 10.1093/ejechocard/jeq116, PubMed 20851818

Grøgaard HK, Seljeflot I, Lunde K, Solheim S, Aakhus S, Forfang K, Arnesen H, Ilebekk A (2010)
Cell treatment after acute myocardial infarction prevents early decline in circulating IGF-1
44 (5), 267-72
DOI 10.3109/14017431.2010.490949, PubMed 21080844

Solheim S, Seljeflot I, Lunde K, Bjørnerheim R, Aakhus S, Forfang K, Arnesen H (2010)
Frequency of left ventricular thrombus in patients with anterior wall acute myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy
106 (9), 1197-200
DOI 10.1016/j.amjcard.2010.06.043, PubMed 21029812

Sverdrup Ø, Jensen T, Solheim S, Gjesdal K (2010)
Training auscultatory skills: computer simulated heart sounds or additional bedside training? A randomized trial on third-year medical students
10, 3
DOI 10.1186/1472-6920-10-3, PubMed 20082701

Weiss TW, Furenes EB, Trøseid M, Solheim S, Hjerkinn EM, Seljeflot I, Arnesen H (2010)
Prediction of cardiovascular events by matrix metalloproteinase (MMP)-9 in elderly men
103 (3), 679-81
DOI 10.1160/TH09-05-0317, PubMed 20076844

Publications 2009

Beitnes JO, Hopp E, Lunde K, Solheim S, Arnesen H, Brinchmann JE, Forfang K, Aakhus S (2009)
Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study
95 (24), 1983-9
DOI 10.1136/hrt.2009.178913, PubMed 19833610

Furenes EB, Arnesen H, Solheim S, Grøgaard HK, Hoffmann P, Seljeflot I (2009)
The profile of circulating metalloproteinases after PCI in patients with acute myocardial infarction or stable angina
124 (5), 560-4
DOI 10.1016/j.thromres.2009.04.001, PubMed 19410278

Taraldsrud E, Grøgaard HK, Solheim S, Lunde K, Fløisand Y, Arnesen H, Seljeflot I, Egeland T (2009)
Age and stress related phenotypical changes in bone marrow CD34+ cells
69 (1), 79-84
DOI 10.1080/00365510802419447, PubMed 18836945

Publications 2008

Christensen AH, Ribic D, Solheim S, Gjesdal K (2008)
[Occurrence of arrhythmias related to treatment of myocardial infarction]
128 (19), 2163-6
PubMed 18846137

Furenes EB, Seljeflot I, Solheim S, Hjerkinn EM, Arnesen H (2008)
Long-term influence of diet and/or omega-3 fatty acids on matrix metalloproteinase-9 and pregnancy-associated plasma protein-A in men at high risk of coronary heart disease
68 (3), 177-84
DOI 10.1080/00365510701663350, PubMed 17934973

Lunde K, Solheim S, Forfang K, Arnesen H, Brinch L, Bjørnerheim R, Ragnarsson A, Egeland T, Endresen K, Ilebekk A, Mangschau A, Aakhus S (2008)
Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-up
51 (6), 674-6
DOI 10.1016/j.jacc.2007.10.032, PubMed 18261689

Solheim S (2008)
Inflammation in various stages of coronary heart disease
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 569, 1 b. (flere pag.)
BIBSYS 080111351, ISBN 978-82-8072-880-7

Solheim S, Grøgaard HK, Hoffmann P, Arnesen H, Seljeflot I (2008)
Inflammatory responses after percutaneous coronary intervention in patients with acute myocardial infarction or stable angina pectoris
68 (7), 555-62
DOI 10.1080/00365510701884584, PubMed 19378426

Solheim S, Seljeflot I, Lunde K, Aukrust P, Yndestad A, Grøgaard HK, Aakhus S, Forfang K, Arnesen H (2008)
Inflammatory responses after intracoronary injection of autologous mononuclear bone marrow cells in patients with acute myocardial infarction
155 (1), 55.e1-9
DOI 10.1016/j.ahj.2007.10.005, PubMed 18082489

Publications 2007

Lunde K, Solheim S, Aakhus S, Arnesen H, Moum T, Abdelnoor M, Egeland T, Endresen K, Ilebekk A, Mangschau A, Forfang K (2007)
Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: results from the Autologous Stem cell Transplantation in Acute Myocardial Infarction (ASTAMI) randomized controlled trial
154 (4), 710.e1-8
DOI 10.1016/j.ahj.2007.07.003, PubMed 17892996

Publications 2006

Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, Endresen K, Ilebekk A, Mangschau A, Fjeld JG, Smith HJ, Taraldsrud E, Grøgaard HK, Bjørnerheim R, Brekke M, Müller C, Hopp E, Ragnarsson A, Brinchmann JE, Forfang K (2006)
Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction
355 (12), 1199-209
DOI 10.1056/NEJMoa055706, PubMed 16990383

Solheim S, Pettersen AA, Arnesen H, Seljeflot I (2006)
No difference in the effects of clopidogrel and aspirin on inflammatory markers in patients with coronary heart disease
96 (5), 660-4
PubMed 17080224

Solheim S, Pettersen AA, Arnesen H, Seljeflot I (2006)
No difference in the effects of clopidogrel and aspirin on inflammatory markers in patients with coronary heart disease
Thromb. Haemost., 96 (5), 660-664
DOI 10.1160/TH06-06-0337

Publications 2005

Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Forfang K, ASTAMI investigators (2005)
Autologous stem cell transplantation in acute myocardial infarction: The ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects
39 (3), 150-8
DOI 10.1080/14017430510009131, PubMed 16152682

Publications 2004

Seljeflot I, Hurlen M, Solheim S, Arnesen H (2004)
Serum levels of interleukin-10 are inversely related to future events in patients with acute myocardial infarction
2 (2), 350-2
DOI 10.1111/j.1538-7933.2004.0584c.x, PubMed 14996010

Publications 2003

Solheim S, Arnesen H, Eikvar L, Hurlen M, Seljeflot I (2003)
Influence of aspirin on inflammatory markers in patients after acute myocardial infarction
92 (7), 843-5
DOI 10.1016/s0002-9149(03)00897-x, PubMed 14516890

Publications 2001

Solheim S, Seljeflot I, Arnesen H, Eritsland J, Eikvar L (2001)
Reduced levels of TNF alpha in hypercholesterolemic individuals after treatment with pravastatin for 8 weeks
157 (2), 411-5
DOI 10.1016/s0021-9150(00)00725-5, PubMed 11472741

Publications 2000

Langberg CW, Solheim S, Hagen S (2000)
[Can radiotherapy reduce the frequency of restenosis after coronary angioplasty?]
120 (6), 707-10
PubMed 10806885